表紙
市場調査レポート

北米における膝関節再建市場の見通し

North America Knee Reconstruction Market Outlook to 2021

発行 GlobalData 商品コード 297091
出版日 ページ情報 英文 170 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
北米における膝関節再建市場の見通し North America Knee Reconstruction Market Outlook to 2021
出版日: 2015年08月07日 ページ情報: 英文 170 Pages
概要

当レポートでは、北米における膝関節再建市場について、初回手術、再置換、部品交換のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 膝関節再建市場の区分
  • 本レポートで対象としている市場の定義

第3章 北米における膝関節再建市場

  • 収益(実績、予測)
  • カテゴリー比較:収益別
  • 収益(実績)
  • 収益(予測)
  • 販売数(実績、予測)
  • 販売数(実績)
  • 販売数(予測)
  • 企業シェア:収益別

第4章 カナダにおける膝関節再建市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第5章 メキシコにおける膝関節再建市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第6章 米国における膝関節再建市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第7章 北米における主要企業の概要

  • Zimmer Holdings, Inc.
  • Stryker Corporation
  • DePuy Companies
  • Biomet, Inc.
  • Smith & Nephew Plc
  • B. Braun Melsungen AG
  • Wright Medical Group, Inc.
  • Exactech, Inc.

第8章 パイプライン製品

第9章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECR0275DB

GlobalData's new report, "North America Knee Reconstruction Market Outlook to 2021", provides key market data on the North America Knee Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Primary Knee Replacement, Revision Knee Replacement and Partial Knee Replacement.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Knee Reconstruction market categories - Primary Knee Replacement, Revision Knee Replacement and Partial Knee Replacement.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Knee Reconstruction market.
  • Global corporate-level profiles of key companies operating within the North America Knee Reconstruction market.
  • Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc., B. Braun Melsungen AG and Wright Medical Group, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Knee Reconstruction Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Knee Reconstruction Market, North America

  • 3.1. Knee Reconstruction Market, North America, Revenue ($m), 2007-2021
  • 3.2. Knee Reconstruction Market, North America, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Knee Reconstruction Market, North America, Revenue ($m), 2007-2014
  • 3.4. Knee Reconstruction Market, North America, Revenue ($m), 2014-2021
  • 3.5. Knee Reconstruction Market, North America, Volume (Units), 2007-2021
  • 3.6. Knee Reconstruction Market, North America, Volume (Units), 2007-2014
  • 3.7. Knee Reconstruction Market, North America, Volume (Units), 2014-2021
  • 3.8. Knee Reconstruction Market, North America, Company Share by Revenue ($m), 2014

4. Knee Reconstruction Market, Canada

  • 4.1. Knee Reconstruction Market, Canada, Revenue ($m), 2007-2014
  • 4.2. Knee Reconstruction Market, Canada, Revenue ($m), 2014-2021
    • 4.2.1. Primary Knee Replacement Market, Canada, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Primary Knee Replacement Market, Canada, Revenue ($m), by Segment, 2014-2021
  • 4.3. Knee Reconstruction Market, Canada, Volume (Units), 2007-2014
  • 4.4. Knee Reconstruction Market, Canada, Volume (Units), 2014-2021
    • 4.4.1. Primary Knee Replacement Market, Canada, Volume (Units), by Segment, 2007-2014
    • 4.4.2. Primary Knee Replacement Market, Canada, Volume (Units), by Segment, 2014-2021
  • 4.5. Knee Reconstruction Market, Canada, Average Price ($), 2007-2021
  • 4.6. Knee Reconstruction Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 4.7. Knee Reconstruction Market, Canada, Company Share by Revenue ($m), 2014

5. Knee Reconstruction Market, Mexico

  • 5.1. Knee Reconstruction Market, Mexico, Revenue ($m), 2007-2014
  • 5.2. Knee Reconstruction Market, Mexico, Revenue ($m), 2014-2021
    • 5.2.1. Primary Knee Replacement Market, Mexico, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Primary Knee Replacement Market, Mexico, Revenue ($m), by Segment, 2014-2021
  • 5.3. Knee Reconstruction Market, Mexico, Volume (Units), 2007-2014
  • 5.4. Knee Reconstruction Market, Mexico, Volume (Units), 2014-2021
    • 5.4.1. Primary Knee Replacement Market, Mexico, Volume (Units), by Segment, 2007-2014
    • 5.4.2. Primary Knee Replacement Market, Mexico, Volume (Units), by Segment, 2014-2021
  • 5.5. Knee Reconstruction Market, Mexico, Average Price ($), 2007-2021
  • 5.6. Knee Reconstruction Market, Mexico, Distribution Share by Revenue ($m), 2013-2014
  • 5.7. Knee Reconstruction Market, Mexico, Company Share by Revenue ($m), 2014

6. Knee Reconstruction Market, United States

  • 6.1. Knee Reconstruction Market, United States, Revenue ($m), 2007-2014
  • 6.2. Knee Reconstruction Market, United States, Revenue ($m), 2014-2021
    • 6.2.1. Partial Knee Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Partial Knee Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
    • 6.2.4. Primary Knee Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
  • 6.3. Knee Reconstruction Market, United States, Volume (Units), 2007-2014
  • 6.4. Knee Reconstruction Market, United States, Volume (Units), 2014-2021
    • 6.4.1. Partial Knee Replacement Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.2. Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2007-2014
    • 6.4.3. Partial Knee Replacement Market, United States, Volume (Units), by Segment, 2014-2021
    • 6.4.4. Primary Knee Replacement Market, United States, Volume (Units), by Segment, 2014-2021
  • 6.5. Knee Reconstruction Market, United States, Average Price ($), 2007-2021
  • 6.6. Knee Reconstruction Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 6.7. Knee Reconstruction Market, United States, Company Share by Revenue ($m), 2014

7. Overview of Key Companies in North America Knee Reconstruction Market

  • 7.1. Zimmer Biomet Holdings, Inc.
    • 7.1.1. Company Overview
  • 7.2. DePuy Companies
    • 7.2.1. Company Overview
  • 7.3. Stryker Corporation
    • 7.3.1. Company Overview
  • 7.4. Biomet, Inc. (Inactive)
    • 7.4.1. Company Overview
  • 7.5. Smith & Nephew Plc
    • 7.5.1. Company Overview
  • 7.6. B. Braun Melsungen AG
    • 7.6.1. Company Overview
  • 7.7. MicroPort Scientific Corporation
    • 7.7.1. Company Overview
  • 7.8. Exactech, Inc.
    • 7.8.1. Company Overview

8. Knee Reconstruction Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Feb 17, 2015: Memorial Health Increases CT Exam Safety and Efficacy with Toshiba's Aquilion ONE
    • 9.1.2. Dec 12, 2014: Zimmer Holdings Names Michael Farrell to Board of Directors
    • 9.1.3. Dec 04, 2014: Brainsway Receives CE Approval for Deep TMS System - OCD
    • 9.1.4. Oct 13, 2014: Amedica Announces Unexpected Passing of Former Chairman of the Board Max E. Link, Ph.D.
    • 9.1.5. Oct 07, 2014: Amedica Appoints Eric A. Stookey to the Board of Directors
    • 9.1.6. Sep 30, 2014: Amedica Appoints New President and Chief Executive Officer
    • 9.1.7. Sep 29, 2014: Amedica Appoints New Vice President of Business Development
    • 9.1.8. Sep 15, 2014: Wright Medical Group, Inc. Appoints Kevin D. Cordell as President, U.S. Extremities
  • 9.2. Financial Announcements
    • 9.2.1. Jul 30, 2015: Zimmer Biomet Reports Second Quarter 2015 Financial Results
    • 9.2.2. Jul 28, 2015: Exactech Q2 2015 Revenue $61.5 Million. Net Income $3.7 Million. Diluted EPS $0.26.
    • 9.2.3. Jul 27, 2015: Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
    • 9.2.4. Jul 23, 2015: Stryker Reports Second Quarter 2015 Results
    • 9.2.5. May 18, 2015: Intra-Cellular Therapies Announces Further Analyses of the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 168th Annual Meeting of the American Psychiatric Association
    • 9.2.6. May 07, 2015: Amedica Reports First Quarter 2015 Financial Results
    • 9.2.7. Apr 30, 2015: Zimmer Holdings Reports First Quarter 2015 Financial Results
    • 9.2.8. Apr 28, 2015: Exactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30.
    • 9.2.9. Apr 21, 2015: Stryker Reports First Quarter 2015 Results
    • 9.2.10. Apr 09, 2015: Biomet Announces Third Quarter of Fiscal Year 2015 Financial Results
    • 9.2.11. Mar 12, 2015: Cynata Therapeutics Commences Further Stage of Stem Cell Manufacturing Program
    • 9.2.12. Mar 05, 2015: Amedica Reports Fourth Quarter and Full Year 2014 Financial Results
    • 9.2.13. Feb 25, 2015: AmSurg Reports Fourth-Quarter and 2014 Results
    • 9.2.14. Feb 24, 2015: Zimmer Holdings Announces Quarterly Dividend for First Quarter of 2015
    • 9.2.15. Feb 17, 2015: Exactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18
    • 9.2.16. Feb 11, 2015: Stryker Declares a 13% Increase in Quarterly Dividend
    • 9.2.17. Jan 29, 2015: Zimmer Holdings Reports Fourth Quarter and Full Year 2014 Financial Results
    • 9.2.18. Jan 27, 2015: Stryker Reports 2014 Results
    • 9.2.19. Jan 13, 2015: Stryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook
    • 9.2.20. Jan 06, 2015: Biomet Announces Second Quarter of Fiscal Year 2015 Financial Results
    • 9.2.21. Dec 23, 2014: Repro Med Systems Announces Strong Results for Third Quarter Ended November 30, 2014
    • 9.2.22. Dec 18, 2014: Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
    • 9.2.23. Dec 15, 2014: Zimmer Holdings Announces Quarterly Dividend for Fourth Quarter of 2014
    • 9.2.24. Dec 04, 2014: Ra Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Complement C5 Inhibitor at 2014 ASH Annual Meeting
    • 9.2.25. Dec 03, 2014: Stryker Declares a 13% Increase in Quarterly Dividend
    • 9.2.26. Nov 06, 2014: Amedica Reports Third Quarter 2014 Financial Results
    • 9.2.27. Nov 06, 2014: Tornier Reports Third Quarter 2014 Results
    • 9.2.28. Nov 05, 2014: Wright Medical Group, Inc. Reports 2014 Third Quarter Financial Results and Updated Guidance
    • 9.2.29. Oct 23, 2014: Pfizer Wins SUTENT Patent Case In Delaware District Court
    • 9.2.30. Oct 23, 2014: Zimmer Holdings Reports Third Quarter 2014 Financial Results
    • 9.2.31. Oct 21, 2014: Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23
    • 9.2.32. Oct 16, 2014: Stryker Reports Third Quarter 2014 Results and 2014 Outlook
    • 9.2.33. Oct 14, 2014: MOLOGEN AG presents EnanDIM: A new generation of immunomodulators
    • 9.2.34. Oct 09, 2014: Biomet Announces First Quarter of Fiscal Year 2015 Financial Results
    • 9.2.35. Aug 07, 2014: Amedica Reports Second Quarter 2014 Financial Results
    • 9.2.36. Aug 05, 2014: Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results
  • 9.3. Government and Public Interest
    • 9.3.1. Jul 09, 2015: CMS proposes major initiative for hip and knee replacements
  • 9.4. Legal And Regulatory
    • 9.4.1. Oct 31, 2014: Biomet to Pay Over $6 Million to Resolve Whistleblower Claims That It Paid Kickbacks to Doctors
    • 9.4.2. Oct 29, 2014: Biomet Companies to Pay Over $6 Million to Resolve False Claims Act Allegations Concerning Bone Growth Stimulators
  • 9.5. Other Significant Developments
    • 9.5.1. Mar 23, 2015: Federally Funded Project Establishes First National Database of Comprehensive Benchmarks for Total Hip and Knee Joint Replacement
    • 9.5.2. Mar 03, 2015: AmSurg Declares Quarterly Preferred Stock Dividend
    • 9.5.3. Feb 10, 2015: Drug targeting Ebola virus protein VP24 shows promise in monkeys
    • 9.5.4. Dec 23, 2014: Micron Products Announces Exclusive Agreement With New Era Orthopaedics
    • 9.5.5. Nov 19, 2014: Oxford Performance Materials Receives Prestigious National Institutes Of Health Grant To Improve Treatment Of Infections Related To Artificial Hips, Knees And Other Implanted Devices
    • 9.5.6. Aug 26, 2014: Zimmer Holdings Announces Quarterly Dividend for Third Quarter of 2014
    • 9.5.7. Aug 21, 2014: Stryker Declares a $0.305 Quarterly Dividend July 2014
  • 9.6. Product News
    • 9.6.1. Mar 24, 2015: Cayenne Medical Continues to Drive Innovation After Decade of Growth
    • 9.6.2. Dec 09, 2014: New National Survey Reveals The Surprising Overall Life Impact Of Joint Pain - It's More Than Physical
    • 9.6.3. Oct 02, 2014: First Total Knee Replacement Surgery Performed at Brookside Surgery Center
  • 9.7. Strategy And Business Planning
    • 9.7.1. Apr 15, 2015: Motif Gains FDA Agreement To Enter Phase 3 Clinical Development With Iclaprim
    • 9.7.2. Jan 20, 2015: InterMed Resources and Amedica Announce Agreement With HealthTrust
    • 9.7.3. Jan 16, 2015: ZIMMER expands Irish Manufacturing presence
    • 9.7.4. Jan 12, 2015: Amedica Announces Steps to Simplify Organization and Align Financial Objectives
    • 9.7.5. Oct 30, 2014: Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing Of The Biomet Transaction
    • 9.7.6. Sep 23, 2014: Stryker plans to construct new Innovation Centre in Cork

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Market Modeling and Forecasting
    • 10.1.5. Company Share Analysis
    • 10.1.6. Distribution Share Analysis
  • 10.2. Expert Panel
  • 10.3. GlobalData Consulting
  • 10.4. Contact Us
  • 10.5. Disclaimer

List of Tables

  • Table 1: Knee Reconstruction Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Knee Reconstruction Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Knee Reconstruction Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Knee Reconstruction Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Knee Reconstruction Market, North America, Volume (Units), 2007-2021
  • Table 6: Knee Reconstruction Market, North America, Volume (Units), Historic, 2007-2014
  • Table 7: Knee Reconstruction Market, North America, Volume (Units), Forecast, 2014-2021
  • Table 8: Knee Reconstruction Market, North America, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Knee Reconstruction Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Knee Reconstruction Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Primary Knee Replacement Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Primary Knee Replacement Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 13: Knee Reconstruction Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 14: Knee Reconstruction Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 15: Primary Knee Replacement Market, Canada, Volume (Units), Historic, 2007-2014
  • Table 16: Primary Knee Replacement Market, Canada, Volume (Units), Forecast, 2014-2021
  • Table 17: Knee Reconstruction Market, Canada, Average Price ($), Historic, 2007-2014
  • Table 18: Knee Reconstruction Market, Canada, Average Price ($), Forecast, 2014-2021
  • Table 19: Knee Reconstruction Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Knee Reconstruction Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Knee Reconstruction Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 22: Knee Reconstruction Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 23: Primary Knee Replacement Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 24: Primary Knee Replacement Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 25: Knee Reconstruction Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 26: Knee Reconstruction Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 27: Primary Knee Replacement Market, Mexico, Volume (Units), Historic, 2007-2014
  • Table 28: Primary Knee Replacement Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Table 29: Knee Reconstruction Market, Mexico, Average Price ($), Historic, 2007-2014
  • Table 30: Knee Reconstruction Market, Mexico, Average Price ($), Forecast, 2014-2021
  • Table 31: Knee Reconstruction Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 32: Knee Reconstruction Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014
  • Table 33: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 34: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 36: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 37: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 38: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 39: Knee Reconstruction Market, United States, Volume (Units), Historic, 2007-2014
  • Table 40: Knee Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 41: Partial Knee Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Table 42: Primary Knee Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Table 43: Partial Knee Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 44: Primary Knee Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 45: Knee Reconstruction Market, United States, Average Price ($), Historic, 2007-2014
  • Table 46: Knee Reconstruction Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 47: Knee Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 48: Knee Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 49: Knee Reconstruction Market Pipeline Products
  • Table 50: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Knee Reconstruction Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Knee Reconstruction Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Knee Reconstruction Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Knee Reconstruction Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Knee Reconstruction Market, North America, Volume (Units), 2007-2021
  • Figure 6: Knee Reconstruction Market, North America, Volume (Units), Historic, 2007-2014
  • Figure 7: Knee Reconstruction Market, North America, Volume (Units), Forecast, 2014-2021
  • Figure 8: Knee Reconstruction Market, North America, Company Share (%) 2014
  • Figure 9: Knee Reconstruction Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Knee Reconstruction Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Primary Knee Replacement Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Primary Knee Replacement Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Knee Reconstruction Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 14: Knee Reconstruction Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 15: Primary Knee Replacement Market, Canada, Volume (Units), Historic, 2007-2014
  • Figure 16: Primary Knee Replacement Market, Canada, Volume (Units), Forecast, 2014-2021
  • Figure 17: Knee Reconstruction Market, Canada, Company Share (%) 2014
  • Figure 18: Knee Reconstruction Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Knee Reconstruction Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Primary Knee Replacement Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 21: Primary Knee Replacement Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 22: Knee Reconstruction Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 23: Knee Reconstruction Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 24: Primary Knee Replacement Market, Mexico, Volume (Units), Historic, 2007-2014
  • Figure 25: Primary Knee Replacement Market, Mexico, Volume (Units), Forecast, 2014-2021
  • Figure 26: Knee Reconstruction Market, Mexico, Company Share (%) 2014
  • Figure 27: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 28: Knee Reconstruction Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 29: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Partial Knee Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 32: Primary Knee Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 33: Knee Reconstruction Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 34: Knee Reconstruction Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 35: Partial Knee Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 36: Primary Knee Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 37: Partial Knee Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 38: Primary Knee Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 39: Knee Reconstruction Market, United States, Company Share (%) 2014
  • Figure 40: GlobalData Epidemiology-Based Forecasting Model
  • Figure 41: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 42: Primary Interviews by Participant Type (%)
Back to Top